Adalimumab Market Current and Future Industry Trends, 2021 to 2028

  • In November 2018, AbbVie Inc. signed a patent license agreement for its product Humira, an adalimumab with the Pfizer Inc. As per the agreement the AbbVie Inc. has granted a non-exclusive license to Pfizer for Humira. This agreement thus helped the company expand its market of adalimumab across different regions of the world.
  • AbbVie Inc.
  • Amgen (Europe) GmbH (A Subsidiary of Amgen Inc.)
  • CELLTRION INC.
  • Samsung Bioepis (a subsidiary of Samsung Biologics)
  • Biogen
  • Coherus BioSciences
  • Innovent Biologics, Inc.
  • Mylan N.V.
  • Zydus Cadila
  • Hetero Biopharma Ltd.
  • Fresenius Kabi Deutschland GmbH (A Subsidiary of Fresenius Kabi AG)
  • Sandoz International GmbH (A Subsidiairy of Sandoz (A Division of Novartis AG))
  • Pfizer Inc.
  • Methodology and Scope
  • Executive Summary
  • Access Control Industry Insights
  • Access Control Market, By Region
  • Company Profile

Global Adalimumab Market Scope And Market Size

  • On the basis of indication, the adalimumab market the market is segmented into rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, chronic plaque psoriasis, crohn’s disease, ulcerative colitis, juvenile idiopathic arthritis, hidradenitis suppurativa, non-infectious intermediate and others. In 2020, rheumatoid arthritis segment is dominating the adalimumab market because it is one of the most common autoimmune systemic inflammatory diseases affecting approximately 1% of the worldwide population. Moreover, worldwide, the annual incidence of rheumatoid arthritis is approximately 3 cases per 10,000 populations.
  • On the basis of type, the adalimumab market is segmented into biologics and biosimilars. In 2020, biologics segment is dominating the adalimumab market because less number of biosimilars drugs present worldwide. Moreover, AbbVie have still patent right on the Humira in the U.S. market.
  • On the basis of dosage strength, the adalimumab market is segmented into 40mg/0.4ml, 80mg/0.8ml, 20mg/0.2ml, 10mg/0.1ml and others. In 2020, 40mg/0.4ml is dominating the adalimumab market because majority of population or patients are suffering from inflammatory disease and are relying on 40mg dose in order to achieve effective treatment.
  • On the basis of drug type, the adalimumab market is segmented into branded and generics. In 2020, branded segment is dominating the adalimumab market because patients are more satisfied with the branded product; moreover AbbVie has marketing right for branded Humira all over the world.
  • On the basis of route of administration, the adalimumab market is segmented into parenteral and oral. In 2020, parenteral segment is dominating the adalimumab market because adalimumab is a human monoclonal antibody can only be given through SC route so as to induce slow and effective long term effect.
  • On the basis of population type, the adalimumab market is segmented into adults and children. In 2020, adults segment is dominating the adalimumab market because adult population have weak immune system and thus are more prone to inflammatory diseases and majority of clinical data supporting adalimumab effectiveness among the adult population.
  • On the basis of end user, the adalimumab market the market is segmented into hospitals, specialty clinics, home healthcare and others. In 2020, hospitals segment is dominating the adalimumab market because of the presence of skilled professionals, moreover hospital provides with the insurance coverage for adalimumab drugs.
  • Highlights key business priorities to assist companies to realign their business strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market and those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest concerning products, segmentation, and industry verticals.

--

--

--

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approach

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

How Grocery Delivery Apps Uplift Physical Grocery Store During COVID-19!

Dollar Tree Making Its Family Dollar Stores More Appealing

Strategies for Sustainability in Uncertain Times

Product-Led Communities Need Picks and Shovels

The Amazon of life and wellbeing

The Future of Mobile Banking

Innovation no longer an option for most fashion companies

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
DataBridge Market Research

DataBridge Market Research

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approach

More from Medium

The “mysteries(secrets)” of investment learned from wise sayings.

Top 3 projects with the highest ROI index

What is Web 3.0? The Evolution of the web

Qi Men Dun Jia Destiny Reading Finding Marriage, Academic & Career Symbols in